Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

iShares MSCI EM UCITS ETF USD (Dist) (IEMM.AS)

Amsterdam - Amsterdam Delayed Price. Currency in EUR
Add to watchlist
38.01+0.62 (+1.66%)
At close: 05:35PM CEST
Advertisement
Full screen
Previous Close37.45
Open37.94
Bid0.00 x 0
Ask0.00 x 0
Day's Range37.73 - 38.08
52 Week Range35.97 - 45.07
Volume1,259
Avg. Volume9,898
Net Assets3.79B
NAV39.08
PE Ratio (TTM)N/A
Yield1.63%
YTD Daily Total Return-16.86%
Beta (5Y Monthly)1.00
Expense Ratio (net)0.18%
Inception Date2005-11-18
  • GlobeNewswire

    Intercept to Present New NASH and PBC Data at the Digital International Liver Congress™ 2021

    New analyses from the Phase 3 REGENERATE study highlight the relationship between early reductions of aminotransferases and fibrosis improvement in patients with fibrosis due to NASH treated with obeticholic acid (OCA) In a real-world study of patients with PBC, Ocaliva® reduced alkaline phosphatase and bilirubin after 1 and 2 years of treatment across patient subgroups NEW YORK, June 21, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused

Advertisement
Advertisement